Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carl H June

Showing results (31-40 of 460) with videos related to

Pageof 46
Sort By:
Best Practice & Research. Clinical Haematology|September 16, 2008
Post-transplant adoptive T-cell immunotherapyNicole A Aqui, Carl H June
Current Topics in Microbiology and Immunology|August 12, 2010
Adoptive cellular therapyStephan A Grupp, Carl H June
Cell Research|December 28, 2016
Driving gene-engineered T cell immunotherapy of cancerLaura A Johnson, Carl H June
Cell|February 11, 2017
The Principles of Engineering Immune Cells to Treat CancerWendell A Lim, Carl H June
Blood|September 9, 2004
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activationJames L Riley, Carl H June
Cell|November 24, 2022
CAR T therapy extends its reach to autoimmune diseasesDaniel J Baker, Carl H June
Nature|November 20, 2019
Trispecific antibodies offer a third way forward for anticancer immunotherapyAlfred L Garfall, Carl H June
The Journal of Clinical Investigation|December 30, 2009
Putting the brakes on BTLA in T cell-mediated cancer immunotherapyChrystal M Paulos, Carl H June
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 30, 2015
T cell engineering as therapy for cancer and HIV: our synthetic futureCarl H June, Bruce L Levine
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
CARTs on the road for myelomaMarcela V Maus, Carl H June
Pageof 46

Showing results (31-40 of 460) with videos related to

Sort By:
Pageof 46
Best Practice & Research. Clinical Haematology|September 16, 2008
Post-transplant adoptive T-cell immunotherapyNicole A Aqui, Carl H June
Current Topics in Microbiology and Immunology|August 12, 2010
Adoptive cellular therapyStephan A Grupp, Carl H June
Cell Research|December 28, 2016
Driving gene-engineered T cell immunotherapy of cancerLaura A Johnson, Carl H June
Cell|February 11, 2017
The Principles of Engineering Immune Cells to Treat CancerWendell A Lim, Carl H June
Blood|September 9, 2004
The CD28 family: a T-cell rheostat for therapeutic control of T-cell activationJames L Riley, Carl H June
Cell|November 24, 2022
CAR T therapy extends its reach to autoimmune diseasesDaniel J Baker, Carl H June
Nature|November 20, 2019
Trispecific antibodies offer a third way forward for anticancer immunotherapyAlfred L Garfall, Carl H June
The Journal of Clinical Investigation|December 30, 2009
Putting the brakes on BTLA in T cell-mediated cancer immunotherapyChrystal M Paulos, Carl H June
Philosophical Transactions of the Royal Society of London. Series B, Biological Sciences|September 30, 2015
T cell engineering as therapy for cancer and HIV: our synthetic futureCarl H June, Bruce L Levine
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 13, 2014
CARTs on the road for myelomaMarcela V Maus, Carl H June
Pageof 46